ACS chemical neuroscience molecule spotlight on BMS-708163.

ABSTRACT: BMS-708163 is a novel, sulfonamide containing γ-secretase inhibitor from Bristol-Myers Squibb Co. currently in Phase II clinical trials for the treatment of Alzheimer's disease (AD).

SUBMITTER: Hopkins CR 

PROVIDER: S-EPMC3369796 | biostudies-other | 2012 Mar

REPOSITORIES: biostudies-other